BASELINE INTERLEUKIN-17A PREDICT TREATMENT RESPONSE TO TOCILIZUMAB AND DISEASE-MODIFYING ANTIRHEUMATIC DRUGS THERAPY

被引：0

作者：

Lee, S. J. ^{[1
,2
,3
]}

Yoon, M. J. ^{[3
]}

Joo, S. H. ^{[3
]}

Park, W. ^{[4
]}

Park, S. H. ^{[5
]}

Shim, S. C. ^{[6
]}

Baek, H. J. ^{[7
]}

Yoo, D. -H. ^{[8
]}

Kim, H. A. ^{[9
]}

Lee, S. K. ^{[10
]}

Lee, Y. J. ^{[11
]}

Park, Y. E. ^{[12
]}

Cha, H. -S. ^{[13
]}

Choi, I. A. ^{[14
]}

Lee, E. Y. ^{[1
,2
]}

Lee, E. B. ^{[1
,2
]}

Song, Y. W. ^{[1
,2
,3
]}

机构：

[1] Seoul Natl Univ, WCU, Grad Sch Convergence Sci & Technol, Seoul, South Korea

[2] Seoul Natl Univ, Coll Med, Med Res Inst, Seoul, South Korea

[3] Seoul Natl Univ Hosp, Div Rheumatol, Seoul 110744, South Korea

[4] Inha Univ Hosp, Div Rheumatol, Seoul, South Korea

[5] Catholic Univ Korea, Seoul St Marys Hosp, Div Rheumatol, Seoul, South Korea

[6] Eulji Univ Hosp, Div Rheumatol, Taejon, South Korea

[7] Gachon Univ, Gil Med Ctr, Div Rheumatol, Inchon, South Korea

[8] Hanyang Univ, Med Ctr, Div Rheumatol, Seoul 133791, South Korea

[9] Hallym Univ, Med Ctr, Div Rheumatol, Seoul, South Korea

[10] Yonsei Univ Hlth Syst, Div Rheumatol, Seoul, South Korea

[11] Seoul Natl Univ, Bundang Hosp, Div Rheumatol, Seoul, South Korea

[12] Pusan Natl Univ Hosp, Div Rheumatol, Pusan, South Korea

[13] Sam Sung Med Ctr, Div Rheumatol, Seoul, South Korea

[14] Chung Buk Natl Univ Hosp, Div Rheumatol, Cheongju, South Korea

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷

关键词：

D O I：

10.1136/annrheumdis-2014-eular.5095

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SAT0059

引用

页码：610 / 611

页数：2

共 50 条

[21] Previous Use of Conventional Disease-Modifying Antirheumatic Drugs and Response to Baricitinib
Kavanaugh, Arthur F.
van Vollenhoven, Ronald F.
Muram, David
Alam, Jahangir
Arora, Vipin
Correia, Ana Luisa de Macedo Pinto
de la Torre, Inmaculada
O'Dell, James R.
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[22] Subcutaneous Tocilizumab Versus Placebo in Combination With Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis
Kivitz, Alan
Olech, Ewa
Borofsky, Michael
Zazueta, Beatriz M.
Navarro-Sarabia, Federico
Radominski, Sebastiao C.
Merrill, Joan T.
Rowell, Lucy
Nasmyth-Miller, Clare
Bao, Min
Wright, Stephen
Pope, Janet E.
ARTHRITIS CARE & RESEARCH, 2014, 66 (11) : 1653 - 1661
[23] Subsequent Therapy of Patients with Biologic Response Modifiers or Disease-Modifying Antirheumatic Drugs After Coccidioidomycosis
Knowles, Susan
Taroumian, Sara
Lisse, Jeffrey R.
Yanes, James
Ampel, Neil M.
Gall, Eric P.
Grau, Rafael G.
Bode, Barbara Y.
Vaz, Berchman A.
Galgiani, John
Hoover, Susan E.
ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S961 - S961
[24] Disease-modifying antirheumatic drug therapy for spondyloarthropathies: advances in treatment
Mease, PJ
CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (03) : 205 - 212
[25] Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs
Sizova, Lyudmila
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (02) : 173 - 178
[26] Inconsistent Treatment with Disease-modifying Antirheumatic Drugs: A Longitudinal Data Analysis
Mjaavatten, Maria D.
Radner, Helga
Yoshida, Kazuki
Shadick, Nancy A.
Frits, Michelle L.
Iannaccone, Christine K.
Kvien, Tore K.
Weinblatt, Michael E.
Solomon, Daniel H.
JOURNAL OF RHEUMATOLOGY, 2014, 41 (12) : 2370 - 2378
[27] Indirect Comparison of Tocilizumab and Other Biologic Agents in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs
Bergman, Gert J. D.
Hochberg, Marc C.
Boers, Maarten
Wintfeld, Neil
Kielhorn, Adrian
Jansen, Jeroen P.
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2010, 39 (06) : 425 - 441
[28] Disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis: Medical education
Top, Cihan
Terekeci, Hakan
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2008, 28 (03): : 387 - 398
[29] Treatment failure with disease-modifying antirheumatic drugs in rheumatoid arthritis patients
Mittal, Niti
Mittal, Rakesh
Sharma, Aman
Jose, Vinu
Wanchu, Ajay
Singh, Surjit
SINGAPORE MEDICAL JOURNAL, 2012, 53 (08) : 532 - 536
[30] The role of disease-modifying antirheumatic drugs in the treatment of giant cell arteritis
Nuenninghoff, DM
Matteson, EL
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2003, 21 (06) : S29 - S34

← 1 2 3 4 5 →